Glioblastoma (GBM) – VT1021 Demonstrates Promising Results
Overview Glioblastoma, GBM, is a type of cancer that affects the central nervous system. It stems from astrocytes, which are special cells that support the
Ovarian Cancer – A New Standard of Care?
Overview Serous ovarian cancer is a relatively uncommon tumor that could be quite challenging to manage, especially when it’s recurrent. Among women, ovarian cancer is
Lung cancer – A novel treatment with Sugemalimab
Overview Smoking tobacco products has made lung cancer one of the most common tumors in the world. The prevalence of lung cancer is especially predominant
New Biological Drug for Melanoma – Relatlimab
Overview Advanced Melanoma is a challenging type of cancer to deal with, especially when it spreads to multiple sites in the body, metastasizes. Moreover, the
Breast Cancer – Elacestrant News
Overview Over the past few years, scientists shifted focus to treating breast cancer with hormonal therapies. This is especially the case when cancer spreads to
Cervical Cancer – New drug combination: Balstilimab Plus Zalifrelimab
Overview Advanced cases of cervical cancer pose a challenge for physicians to treat. Once the cancer cells have spread to other tissues, procedures such as
Lung cancer – Tiragolumab Plus Atezolizumab Survival
Overview Lung cancer is a very challenging condition to manage, especially when discovered late. The incredibly high incidence of lung cancer – mostly caused by
Breast Cancer – NERLYNX for Leptomeningeal Metastases
Overview The spread of cancer cells beyond the original site of the tumor is a very challenging process. When cancer cells of the breast are
Glioblastoma – A New Combination Treatment You Need to Know
Overview Glioblastoma, or GBM, is an aggressive type of tumor that occurs in the brain. Due to the location of this tumor and the limited
Cholangiocarcinoma and Gallbladder Cancer – Breakthrough with Imfinzi
Overview Ever since their discovery, advanced cases of cholangiocarcinoma and gallbladder cancers have been a big issue for doctors to manage. Since these cancers only
Rechallenge Treatment for Metastatic Colorectal Cancer Patients
Overview Over the past few years, researchers have been trying to find new treatment protocols for colorectal cancer by combining anticancer drugs. Fortunately, these efforts
Melanoma – Alrizomadlin, Fast Track Designation for Advanced Disease
Overview The FDA has granted a Fast Track Designation to the novel MDM2-p53 inhibitor named “Alrizomadlin” (APG-115) for the treatment of patients with unresectable or
